Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
gilead sciences
kymriah
life sciences
medicare
national blog main
national top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
yescarta
2
×
abbvie
adverum biotechnologies
albert bourla
alzheimer's disease
amgen
amicus therapeutics
arvinas
batten disease
bayer
biobucks
biogen
boulder/denver blog main
boulder/denver top stories
breast cancer
brian stuglik
calistoga pharmaceuticals
cancer diagnostics
cancer immunotherapy
car-t immunotherapy
casimir trials
celenex
checkpoint inhibitors
christine mcsherry
chuck schumer
clinial trials
crispr therapeutics
What
drug
2
×
acquisitions
adding
albert
bets
biggest
bio
boost
bourla
cancer
ceo
company
crispr
expensive
far
future
gilead
imports
maker
maps
measured
million
patients
paying
pfizer
pfizer’s
pipeline
program
revenue
roundup
sciences
startup
startup's
tango
tap
therapeutics
tiny
today
world’s
Language
unknown
Current search:
yescarta
×
drug
×
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango